Dumchev, Kostyantyn
Guo, Xu
Ha, Tran Viet
Djoerban, Zubairi
Zeziulin, Oleksandr
Go, Vivian F.
Sarasvita, Riza
Metzger, David S.
Latkin, Carl A.
Rose, Scott M.
Piwowar-Manning, Estelle
Richardson, Paul
Hanscom, Brett
Lancaster, Kathryn E.
Miller, William C.
Hoffman, Irving F.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068619, UM1AI068617, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068613, UM1AI068613, UM1AI068617, UM1AI068619, UM1AI068619, UM1AI068619)
Article History
Received: 9 October 2022
Accepted: 27 March 2023
First Online: 11 May 2023
Declarations
:
: All study procedures were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants enrolled in HPTN 074. The study protocol was approved by the following institutional review boards: Ukrainian Institute on Public Health Policy IRB#1 (Ukraine); Ethical Review Board for Biomedical Research Hanoi School of Public Health (Vietnam); Ethics Committee of Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital (Indonesia); and the Institutional Review Board at the University of North Carolina-Chapel Hill.
: Not applicable.
: This study was supported by the National Institutes of Health (NIH) and multiple investigators received grants or support from NIH (IFH, BH, TVH, CAL, DSM, KEL, VFG, EPM, PR, and WCM). All other authors declare no competing interests.